Philadelphia, PANCT07587021Now EnrollingIRB Ready

Primary Hyperoxaluria Type 1 Clinical Trial in Philadelphia, PA

Access cutting-edge primary hyperoxaluria type 1 treatment through this phase 2 clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by YolTech Therapeutics Co., Ltd

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access primary hyperoxaluria type 1 specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary hyperoxaluria type 1 treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this primary hyperoxaluria type 1 clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Primary Hyperoxaluria Type 1 Study in Philadelphia

This study will be conducted to evaluate the efficacy and safety of YOLT-203 in children and adults with Primary Hyperoxaluria Type 1. After the initial randomized, 6-month double-blind, placebo-controlled period, participants who were initially assigned to placebo will receive a single-dose of YOLT-203 treatment whereas participants in the YOLT-203 group will receive a single-dose of placebo infusion. For patients interested in additional information on how to participate, please follow this link: https://mytomorro.ws/ph1trial.

Sponsor: YolTech Therapeutics Co., Ltd

Who Can Participate

Inclusion Criteria

You are 6 years old or older.
You have been diagnosed with PH1 (primary hyperoxaluria type 1) through genetic testing.
Urine tests show that your oxalate levels are not within certain limits (based on at least two 24-hour urine collections).
If you take vitamin B6, your dose has been stable for at least 3 months, and you are willing to keep it the same during the study.
You (and/or your parent or legal guardian, if you are under 18) understand the study and agree to follow all study requirements, including signing a consent form.

Exclusion Criteria

You have signs that oxalate has affected parts of your body outside the kidneys.
Your liver blood tests are not within certain limits.
You have certain abnormal blood clotting results (unless controlled with medication like warfarin).
You have HIV, or active or chronic hepatitis C.
You are pregnant, planning to become pregnant, or breastfeeding.
You are not willing to use birth control during the study and for 6 months after (if applicable).
You are unable to limit alcohol intake to no more than about 2 drinks per day.
You have had alcohol or drug abuse in the past year.
You are unable to follow standard treatments for PH1 (such as drinking plenty of fluids, taking prescribed medications like potassium citrate, or following dietary advice).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT07587021) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Hyperoxaluria Type 1 Treatment Options in Philadelphia, PA

If you're searching for primary hyperoxaluria type 1 treatment options in Philadelphia, PA, this clinical trial (NCT07587021) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced primary hyperoxaluria type 1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary hyperoxaluria type 1 clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Philadelphia, PA

See all pulmonary embolism clinical trials recruiting in Philadelphia — not just this study.

Browse Pulmonary Embolism Trials in Philadelphia →

Browse More Trials by Condition

Pulmonary Embolism TrialsAll Conditions →

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA